Work

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma

Year: 2025

Type: article

Study design: Observational Study

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2025.102330

Authors: Hannah D McManus, Jessica B Long, Sarah J Westvold, Michael S Leapman, Michael E Hurwitz, Aaron P Mitchell, Craig Evan Pollack, Cary P Gross, Michaela A Dinan

Institutions: Duke University, Duke Medical Center, Yale University, Memorial Sloan Kettering Cancer Center, Johns Hopkins University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: Disparities in the Use of Oral Anticancer Agents in Kidney Cancer, Cancer Center Support Grant

OpenAlex ID: W4408475655

FWCI:

Cites: 28

Cited by:

Related to: 10